INFLUENCE OF MUMIJO ON COAGULATION AND FIBRINOLYTIC ACTIVITY

Authors

  • Zagrutdinov Fanil Faridovich Andijan State Medical Institute, Department of Pharmacology, Clinical Pharmacology, and Medical Biotechnology. Author

Keywords:

Keywords: Traditional medicine (TM) represents an extensive and culturally diverse body of knowledge, practices, skills, and therapeutic approaches that have been transmitted, modified, and developed across generations within different societies.

Abstract

 Mumijo (Shilajit) is a traditional herbo-mineral substance widely used for its reported therapeutic and biological properties. The present study evaluated the effects of Mumijo on selected coagulation and fibrinolytic parameters. Blood clotting time, plasma recalcification time, plasma tolerance to heparin, thrombin time, fibrinogen concentration, fibrinolytic activity, and total plasma protein were assessed at baseline and after 30 and 60 minutes of administration. Mumijo produced a marked prolongation of blood clotting time and thrombin time. Plasma recalcification time and plasma tolerance to heparin also increased progressively during the observation period. Fibrinolytic parameters showed a significant time-dependent change at 60 minutes, while fibrinogen concentration showed a temporary reduction. Total plasma protein remained relatively stable. These findings suggest that Mumijo may influence the coagulation–fibrinolytic system and may possess hemostasis-modulating or anticoagulant properties. Further studies are required to determine the underlying mechanisms, dose dependence, safety, and clinical significance of these effects.

References

1.Qi Z, Kelley E. The WHO Traditional Medicine Strategy 2014-2023: A perspective. Science. 2014;346:S5-S6.

2.“WHO Traditional Medicine Strategy 2014-2023”. World Health Organization Retrieved 2014-04-20. 2013.

3.Shahriari M, Zare F, Nimrouzi M. The Curative Role of Bitumen in Traditional Persian Medicine. Acta Med Hist Adriat. 2018;16(2):283-92.

4.Olivieri MF, Marzari F, Kesel AJ, Bonalume L, Saettini F. Pharmacology and psychiatry at the origins of Greek medicine: The myth of Melampus and the madness of the Proetides. J Hist Neurosci. 2017;26(2):193-215.

5. Shirbeigi L ZA, Naghizadeh A, Alizadeh Vaghasloo M. The Concept of Temperaments in Traditional Persian Medicine. Trad Integr Med. 2017;2(3):143-56.

6. Frolova N, Kiseleva L, Tatiana. Chemical composition of mumijo and methods for determining its authenticity and quality (a review). Pharma Chem J. 1996;30(8):543-7.

7.Agarwal SP, Khanna R, Karmarkar R, Anwer MK, Khar RK. Shilajit: a review. Phytother Res. 2007;21(5):401-5.

8.Verma A, Kumar N, Gupta L, Chaudhary S. Shilajitin Cancer Treatment: Probable Mode of Action. Int J Pharmaceutic Bio Arch. 2016;7(1):12-6.

9. Stohs SJ, Singh K, Das A, Roy S, Sen CK. 12-Energy and Health Benefits of Shilajit. In: Bagchi D, editor. Sustained Energy for Enhanced Human Functions and Activity. Academic Press; 2017. p. 187-204

10.Ghosal S, Lal J, Singh SK, Goel RK, Jaiswal AK, Bhattacharya SK. The need for formulation of Shilajit by its isolated active constituents. Phytother Res. 1991;5(5):211-6

11.Trivedi N, Mazumdar B, Bhatt J, Hemavathi K. Effect of shilajit on blood glucose and lipid profile in alloxaninduced diabetic rats. Indian J Pharmacol. 2004;36(6):373-6.

12.Загрутдинов Ф.Ф., Мамадалиев Ш.И., Болтабоева Д.Ф. Влияние Среднеазиатских Видов Мумиё на диурез и натрий урез у Крыс. Open Herald: Periodical of Methodical Research. Volume 2, Issue 5, May, 2024, 12-14

Downloads

Published

2026-10-27